Theory that Medicaid is fueling opioid crisis challenged
Program helps mitigate crisis, some researchers counter
WASHINGTON — A new theory is gaining traction among conservative foes of the Obama-era health law: Its Medicaid expansion to low-income adults may be fueling the opioid epidemic.
If true, that would represent a shocking outcome for the Affordable Care Act. But there’s no evidence to suggest that’s happening, say university researchers who study the drug problem and are puzzled by such claims. Some even say Medicaid may be helping mitigate the consequences of the epidemic.
Circulating in conservative media, the Medicaid theory is bolstered by a private analysis produced by the Health and Human Services Department for Sen. Ron Johnson, R-Wis. The analysis says the overdose death rate rose nearly twice as much in states that expanded Medicaid compared with states that didn’t.
Independent experts say the analysis misses some crucial facts.
Johnson has asked the agency’s internal watchdog to investigate, suggesting that unscrupulous individuals may be using their new Medicaid cards to obtain large quantities of prescription painkillers and diverting the pills to street sales for profit.
“These data appear to point to a larger problem,” Johnson wrote. “Medicaid expansion may be fueling the opioid epidemic in communities across the country.” He stopped just short of fingering Medicaid, saying more research is needed.
But if anything, university researchers say Medicaid seems to be doing the opposite of what conservatives allege.
“Medicaid is doing its job” by increasing treatment for opioid addiction, said Temple University economist Catherine Maclean, who recently published a paper on Medicaid expansion and drug treatment. “As more time passes, we may see a decline in overdoses in expansion states relative to nonexpansion states.”
Trump administration officials, including Health Secretary Tom Price and Seema Verma, head of the Centers for Medicare and Medicaid Services, have criticized Medicaid, saying the program doesn’t deliver acceptable results.
Price’s agency would not answer questions about the analysis for Johnson, and released a statement instead.
“Correlation does not necessarily prove causation, and additional research is required before any conclusions can be made,” the statement said.
Medicaid is a federal-state program that covers more than 70 million lowincome people. Thirty-one states have expanded Medicaid to serve able-bodied adults, while 19 have not. The expansion went into effect in January 2014, and the most recent national overdose death numbers are for 2015.
That leaves researchers with just a small slice of data. Both sides agree more research is needed. Still, some patterns are emerging. Prescriptions for medications used to treat opioid addiction in outpatient settings increased by 43 percent in Medicaid expansion states compared with states that didn’t expand, according to Maclean’s research with Brendan Saloner of Johns Hopkins Bloomberg School of Public Health. That indicates Medicaid is paying for treatment.
Maclean and Saloner also found another piece of the puzzle: Overdose death rates were higher to begin with in states that expanded Medicaid. That suggests that drug problems may have contributed to state decisions to expand Medicaid.